Business ❯Pharmaceutical Industry ❯Acquisitions

J.P. Morgan Healthcare Conference

2024 Outlook J&J and Ambrx Deal Pharma Industry Outlook

Johnson & Johnson Acquires Ambrx Biopharma for $2 Billion